CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Saecondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Key Findings

3.2.1 Top Investment Pockets
3.2.2 Top Winning Strategies

3.3 Porters Five Forces Analysis

3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 High Intensity of Rivalry
3.3.5 Threat of Substitutes

3.4 Top Player Positioning, 2015
3.5 Market Dynamics

3.5.1 Drivers

3.5.1.1 Increasing aging population
3.5.1.2 Increased incidence of chronic diseases
3.5.1.3 Increased focus on R&D

3.5.2 Restraints

3.5.2.1 organ shortage worldwide
3.5.2.2 Difficulties in HLA sequencing

3.5.3 Opportunities

3.5.3.1 Shift from traditional methods to modern techniques for HLA typing
3.5.3.2 Increasing demand for organ transplant procedures
3.5.3.3 Mergers & acquisitions

CHAPTER 4 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY

4.1 Overview

4.1.1 Market Size and Forecast

4.2 Non-Molecular Assays

4.2.1 Key Market Trends
4.2.2 Key Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.4 Serological Assays

4.2.4.1 Market size and forecast

4.2.5 Mixed Lymphocyte Culture Assays

4.2.5.1 Market size and forecast

4.3 Molecular Assays

4.3.1 Key Market Trends
4.3.2 Key Growth Factors and Opportunities
4.3.3 Market Size and Forecast

4.3.3.1 PCR-based molecular assay
4.3.3.2 Market size and forecast
4.3.3.3 sequencing-based molecular assay
4.3.3.4 Market size and forecast

CHAPTER 5 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY COMPONENT

5.1 Overview
5.2 Consumables and Reagents

5.2.1 Market Size and Forecast

5.3 Instruments and Equipment

5.3.1 Market Size and Forecast

5.4 Software and Services

5.4.1 Market Size and Forecast

CHAPTER 6 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY END USER

6.1 Overview

6.1.1 Market Size and Forecast

6.2 Hospitals and Transplant Centers

6.2.1 Market Size and Forecast

6.3 Research Laboratories and Academic Institutions

6.3.1 Market Size and Forecast

6.4 Commercial Service Providers

6.4.1 Market Size and Forecast

CHAPTER 7 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION

7.1 Overview
7.2 Research

7.2.1 Market Size and Forecast

7.3 Diagnostics

7.3.1 Market Size and Forecast

CHAPTER 8 WORLD TRANSPLANT DIAGNOSTICS MARKET BY ORGAN TYPE

8.1 Overview
8.2 Kidney

8.2.1 Market size and forecast

8.3 Liver

8.3.1 Market size and forecast

8.4 Heart

8.4.1 Market size and forecast

8.5 Lung

8.5.1 Market size and forecast

8.6 Pancreas

8.6.1 Market size and forecast

8.7 Others

8.7.1 Market size and forecast

CHAPTER 9 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY TYPE OF SCREENING

9.1 Overview
9.2 Pretransplant Screening

9.2.1 Market Size and Forecast

9.3 Posttransplant Screening

9.3.1 Market Size and Forecast

CHAPTER 10 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY GEOGRAPHY

10.1 Overview

10.1.1 Market Size and Forecast

10.2 North America

10.2.1 Key Market Trends
10.2.2 Key Growth Factors and Opportunities
10.2.3 Market Size and Forecast
10.2.4 U.S.: Market Size and Forecast
10.2.5 Canada: Market Size and Forecast
10.2.6 Mexico: Market Size and Forecast

10.3 Europe

10.3.1 Key Market Trends
10.3.2 Key Growth Factors and Opportunities
10.3.3 Market Size and Forecast
10.3.4 UK: Market Size and Forecast
10.3.5 Germany: Market Size and Forecast
10.3.6 France: Market Size and Forecast
10.3.7 Spain: Market Size and Forecast
10.3.8 Italy: Market Size and Forecast
10.3.9 Turkey: Market Size and Forecast
10.3.10 Rest of Europe: Market Size and Forecast

10.4 Asia-Pacific

10.4.1 Key Market Trends
10.4.2 Key Growth Factors and Opportunities
10.4.3 Market Size and Forecast
10.4.4 Australia: Market Size and Forecast
10.4.5 South Korea: Market Size and Forecast
10.4.6 New Zealand: Market Size and Forecast
10.4.7 China: Market Size and Forecast
10.4.8 Japan: Market Size and Forecast
10.4.9 Rest of Asia-Pacific: Market Size and Forecast

10.5 LAMEA

10.5.1 Key Market Trends
10.5.2 Key Growth Factors and Opportunities
10.5.3 Market Size and Forecast
10.5.4 Brazil: Market Size and Forecast
10.5.5 Israel: Market Size and Forecast
10.5.6 Iran: Market Size and Forecast
10.5.7 Saudi Arabia: Market Size and Forecast
10.5.8 Rest of LAMEA: Market Size and Forecast

CHAPTER 11 COMPANY PROFILES

11.1 Immucor, Inc. (TPG Capital)

11.1.1 Company overview
11.1.2 Operating business segments
11.1.3 Business performance
11.1.4 Key strategic moves & developments

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Company overview
11.2.2 Operating business segments
11.2.3 Business performance
11.2.4 Key strategic moves & developments

11.3 Thermo Fisher Scientific Inc.

11.3.1 Company overview
11.3.2 Operating business segments
11.3.3 Business performance
11.3.4 Key strategic moves & developments

11.4 F. Hoffmann-la Roche AG

11.4.1 Company overview
11.4.2 Operating business segments
11.4.3 Business performance
11.4.4 Key strategic moves & developments

11.5 Illumina, Inc.

11.5.1 Company overview
11.5.2 Operating business segments
11.5.3 Business performance
11.5.4 Key strategic moves & developments

11.6 Abbott Laboratories

11.6.1 Company overview
11.6.2 Operating business segments
11.6.3 Business performance
11.6.4 Key strategic moves & developments

11.7 Sigma-Aldrich Corporation

11.7.1 Company overview
11.7.2 Operating business segments
11.7.3 Business performance

11.8 Qiagen N.V.

11.8.1 Company overview
11.8.2 Operating business segments
11.8.3 Business performance
11.8.4 Key strategic moves & developments

11.9 Olerup SSP AB (Allenex)

11.9.1 Company overview
11.9.2 Key strategic moves & developments

11.10 DiaSorin S.P.A.

11.10.1 Company overview
11.10.2 Operating business segments
11.10.3 Business performance
11.10.4 Key strategic moves & developments